Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPL | P40238 | 6/20 | 0.54 |
| ▸ | CTRC | Q99895 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | APP | P05067 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | SNCA | P37840 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.48 |
| ▸ | SUMO2 | P61956 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23787709 | 0.86 | APP (0.67) | MPLCTRCTHRBHPGDAPP | |
| SCHEMBL23787671 | 0.84 | PHLPP2 (0.58) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL23787722 | 0.84 | MPL (0.54) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL23787537 | 0.82 | MPL (0.52) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL23787723 | 0.81 | APP (0.75) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL23787729 | 0.81 | APP (0.53) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL23787590 | 0.80 | CYP1A2 (0.49) | MPLCTRCCYP1A2THRBMEN1 | |
| SCHEMBL23787672 | 0.79 | PHLPP2 (0.59) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL15120313 | 0.79 | SENP2 (0.72) | MPLCTRCCYP1A2THRBHPGD | |
| SCHEMBL11695732 | 0.79 | SENP2 (0.72) | MPLCTRCCYP1A2THRBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210275548-A1 | NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF | ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210275548-A1 | NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF | POLG, POLB, POLA1 | MPL 2115/4885CTRC 3691/4885CYP1A2 4524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.